Evidence-based treatment for opioid use disorder is widely unavailable and often discouraged by providers of residential substance use services in North Carolina

被引:0
|
作者
Carroll, Jennifer J. [1 ]
Dasgupta, Nabarun [2 ]
Ostrach, Bayla [3 ,4 ]
El-Sabawi, Taleed [5 ]
Dixon, Sarah [1 ]
Morrissey, Brandon [1 ]
Saucier, Roxanne [6 ]
机构
[1] North Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA
[2] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA
[3] Boston Univ, Dept Family Med, Med Anthropol, Boston, MA USA
[4] Fruit Lab Act Res & Tech Assistance LLC, Fairview, NC USA
[5] Florida Int Univ, Sch Law, Miami, FL USA
[6] Open Soc Fdn, New York, NY USA
基金
美国国家卫生研究院;
关键词
Addiction; Opioid use disorder; Treatment; Buprenorphine; Opioid agonist treatment;
D O I
10.1016/j.josat.2024.209474
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Opioid agonist treatment (OAT) is the only treatment for opioid use disorder (OUD) proven to reduce overdose mortality, yet access to this evidence-based treatment remains poor. The purpose of this crosssectional audit study was to assess OAT availability at residential substance use services in North Carolina. Methods: We conducted a state-wide inventory of residential substance use service providers in North Carolina and subsequently called all providers identified, posing as uninsured persons who use heroin, seeking treatment services. Program characteristics, as reported in phone calls, were systematically recorded. We used Fisher's exact tests to assess what program characteristics were associated with OAT availability and with staff making discouraging comments about OAT. We used unsupervised agglomerative clustering to identify facilities with similar characteristics. Results: Of the 94 treatment providers identified, we successfully contacted and collected data from 66. Of those, only 7 (10.6 %) provide OAT on site; an additional 9 (13.6 %) allow OAT through an outside or community-based prescriber. Only 8 (12.1 %) providers were licensed to provide residential substance use treatment. Staff from 33 (50.0 %) providers made negative, discouraging, or stigmatizing remarks about OAT-for example, that OAT substitutes one addiction for another or does not constitute "true recovery." OAT availability was positively associated with a provider holding a state license for any substance use-related service (41.9 % vs 8.6 %, p = 0.002) and offering 12-step programming (36.1 % vs. 10/0 %, p = 0.020). OAT availability was negatively associated with faith-based programming (6.1 % vs 42.4%, p = 0.001), dress codes (5.3 % vs 50.0%, p < 0.001), and mandates that residents work in a provider-owned and-operated commercial enterprise (5.0 % vs 32.6 %, p = 0.026). Cluster analysis revealed that the most common (n = 21) type of service provider in North Carolina is an unlicensed, faith-based organization that prohibits OAT, imposes a dress code, and mandates that residents work, often in provider-owned and-operated commercial enterprises. Conclusion: Evidence-based treatments for OUD are largely unavailable at providers of residential substance use services in North Carolina. The prohibition of OAT occurs most often among providers who are unlicensed and impose labor and/or 12-step mandates on residents. Changes to state licensure requirements and exemptions may help improve OAT availability.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] ASSESSING EVIDENCE-BASED PRACTICES AND ADOPTION OF EVIDENCE-BASED PRACTICES AMONG SUBSTANCE USE DISORDER TREATMENT PROVIDERS
    Gifford, Elizabeth
    Pierson, Heather
    Cook, Joan
    Weingardt, Ken
    Rosen, Craig
    Curran, Geoffrey
    Hagedorn, Hildi
    Wiesner, Michael
    Finney, John
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S45 - S45
  • [2] EVIDENCE-BASED TREATMENT FOR YOUNG ADULTS WITH SUBSTANCE USE DISORDER
    Hadland, Scott
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S23 - S24
  • [3] Evidence-Based Assessment of Substance Use Disorder
    Boness, Cassandra L.
    Gonzalez, Juan Carlos
    Sleep, Chelsea
    Venner, Kamilla L.
    Witkiewitz, Katie
    [J]. ASSESSMENT, 2024, 31 (01) : 168 - 190
  • [4] Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers
    Pasman, Emily
    Lee, Guijin
    Kollin, Rachel
    Rodriguez, Brooke
    Agius, Elizabeth
    Madden, Erin Fanning
    Resko, Stella M.
    [J]. SUBSTANCE USE & MISUSE, 2022, 57 (12) : 1828 - 1836
  • [5] Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies
    Fadus, Matthew C.
    Squeglia, Lindsay M.
    Valadez, Emilio A.
    Tomko, Rachel L.
    Bryant, Brittany E.
    Gray, Kevin M.
    [J]. CURRENT PSYCHIATRY REPORTS, 2019, 21 (10)
  • [6] Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies
    Matthew C. Fadus
    Lindsay M. Squeglia
    Emilio A. Valadez
    Rachel L. Tomko
    Brittany E. Bryant
    Kevin M. Gray
    [J]. Current Psychiatry Reports, 2019, 21
  • [7] Implementing Evidence-Based Guidelines to Improve Recognition, Reporting, and Treatment of Substance Use Disorder Among Anesthesia Providers
    Schultz, Nancy
    [J]. NURSING RESEARCH, 2013, 62 (02) : E79 - E79
  • [8] Implementing evidence-based substance use prevention curricula in north Carolina public school districts
    Pankratz, MM
    Hallfors, DD
    [J]. JOURNAL OF SCHOOL HEALTH, 2004, 74 (09) : 353 - 358
  • [9] SCREENING FOR COGNITIVE IMPAIRMENT IN RESIDENTIAL SUBSTANCE USE DISORDER TREATMENT SERVICES
    Berry, Jamie
    Sedwell, Antoinette
    Lunn, Jo
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 : S27 - S27
  • [10] Use of evidence-based substance use treatment practices in Mississippi
    Robertson, Angela
    Walker, Courtney S.
    Stovall, Mark
    McCluskey, Lee
    [J]. EVALUATION AND PROGRAM PLANNING, 2015, 52 : 198 - 204